AAAAAA

   
Results: 1-7 |
Results: 7
Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition
Authors: Spenlehauer, C Kirn, A Aubertin, AM Moog, C
Citation: C. Spenlehauer et al., Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition, J VIROLOGY, 75(5), 2001, pp. 2235-2245
Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients
Authors: Burrer, R Salmon-Ceron, D Richert, S Pancino, G Spiridon, G Haessig, S Roques, V Barre-Sinoussi, F Aubertin, AM Moog, C
Citation: R. Burrer et al., Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients, J VIROLOGY, 75(11), 2001, pp. 5421-5424
Generation of CD8(+) T cell-generated suppressor factor and beta-chemokines by targeted iliac lymph node immunization in rhesus monkeys challenged with SHIV-89.6P by the rectal route
Authors: Aubertin, AM Le Grand, R Wang, YF Beyer, C Tao, L Neildez, O Barre-Sinoussi, F Hurtrel, B Moog, C Lehner, T Girard, M
Citation: Am. Aubertin et al., Generation of CD8(+) T cell-generated suppressor factor and beta-chemokines by targeted iliac lymph node immunization in rhesus monkeys challenged with SHIV-89.6P by the rectal route, AIDS RES H, 16(4), 2000, pp. 381-392
Immunisation with whole purified human immunodeficiency virus type 1 particles elicits enhancing antibodies in rhesus macaques
Authors: Verrier, F Moog, C Barre-Sinoussi, F Van der Ryst, E Spenlehauer, C Girard, M
Citation: F. Verrier et al., Immunisation with whole purified human immunodeficiency virus type 1 particles elicits enhancing antibodies in rhesus macaques, B ACA N MED, 184(1), 2000, pp. 67-87
Safety and immunogenicity of a live recombinant canarypox virus expressingHIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection
Authors: Salmon-Ceron, D Excler, JL Finkielsztein, L Autran, B Gluckman, JC Sicard, D Matthews, TJ Meignier, B Valentin, C El Habib, R Blondeau, C Raux, M Moog, C Tartaglia, J Chong, P Klein, M Milcamps, B Heshmati, F Plotkin, S
Citation: D. Salmon-ceron et al., Safety and immunogenicity of a live recombinant canarypox virus expressingHIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection, AIDS RES H, 15(7), 1999, pp. 633-645
Enhanced HIV infectivity and changes in GP120 conformation associated withviral incorporation of human leucocyte antigen class I molecules
Authors: Cosma, A Blanc, D Braun, J Quillent, C Barassi, C Moog, C Klasen, S Spire, B Scarlatti, G Pesenti, E Siccardi, AG Beretta, A
Citation: A. Cosma et al., Enhanced HIV infectivity and changes in GP120 conformation associated withviral incorporation of human leucocyte antigen class I molecules, AIDS, 13(15), 1999, pp. 2033-2042
Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro
Authors: Moog, C Aubertin, AM Kirn, A Luu, B
Citation: C. Moog et al., Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro, ANTIVIR CHE, 9(6), 1998, pp. 491-496
Risultati: 1-7 |